Phio Pharmaceuticals Corp Stock In The News
| PHIO Stock | USD 2.72 0.08 3.03% |
Our overall analysis of Phio Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Phio Pharmaceuticals Corp. The specific impact of Phio Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Phio Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Phio Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Phio Pharmaceuticals Backtesting and Phio Pharmaceuticals Hype Analysis.
Phio |
Phio Pharmaceuticals Today Top News and Investor Outlook
Phio Pharmaceuticals Corp Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Phio and other traded companies coverage with news coverage. We help investors stay connected with Phio headlines for the 30th of November to make an informed investment decision based on correlating the impacts of news items on Phio Stock performance. Please note that trading solely based on the Phio Pharmaceuticals Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Phio Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Phio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Phio Pharmaceuticals that are available to investors today. That information is available publicly through Phio media outlets and privately through word of mouth or via Phio internal channels. However, regardless of the origin, that massive amount of Phio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phio Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phio Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phio Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phio Pharmaceuticals alpha.
Phio Largest EPS Surprises
Earnings surprises can significantly impact Phio Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -1.43 | -1.14 | 0.29 | 20 | ||
2021-11-10 | 2021-09-30 | -3 | -3.36 | -0.36 | 12 | ||
2024-04-01 | 2024-03-31 | -1.3 | -0.85 | 0.45 | 34 | ||
2024-03-20 | 2023-12-31 | -1.3 | -0.85 | 0.45 | 34 | ||
2022-03-22 | 2021-12-31 | -3.84 | -3.24 | 0.6 | 15 | ||
2021-08-12 | 2021-06-30 | -3.12 | -2.4 | 0.72 | 23 |
Phio Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Phio Pharmaceuticals Corp Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
29th of November 2024
Acquisition by Dispersyn Gerrit of 68450 shares of Phio Pharmaceuticals subject to Rule 16... at MacroaxisInsider
7th of November 2024
Phio Pharmaceuticals Announces Upcoming Presentation at the th Annual Meeting of the Socie... at finance.yahoo.com
24th of October 2024
Phio Pharmaceuticals Announces Upcoming Presentation at the th Annual Meeting of the Socie... at finance.yahoo.com
7th of October 2024
Phio Announces Data Showcasing INTASYLs Role in Helping Immune Cells Target and Kill Cance... at finance.yahoo.com
25th of September 2024
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oli... at finance.yahoo.com
12th of September 2024
Acquisition by Lockshin Curtis of 2000 shares of Phio Pharmaceuticals subject to Rule 16b-... at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Phio Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Phio Pharmaceuticals' short interest history, or implied volatility extrapolated from Phio Pharmaceuticals options trading.
Check out Phio Pharmaceuticals Backtesting and Phio Pharmaceuticals Hype Analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.81) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.